Passive Transfer of Hepatitis B Core Antibody after Intravenous Immunoglobulin Administration in Patients with Cancer: Retrospective Chart Review

BACKGROUND: Patients positive for hepatitis B core antibody (anti-HBc) may experience hepatitis B reactivation during cancer chemotherapy. Intravenous immunoglobulin (IVIG) used in supportive care can produce passive transfer of anti-HBc. We estimated the probability of passive transfer of anti-HBc...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Lancet Haematol
Autori principali: Lu, Huifang, Lok, Anna S., Warneke, Carla L., Ahmed, Sairah, Torres, Harrys A., Martinez, Fernando, Suarez-Almazor, Maria E., Foreman, Jessica T., Ferrajoli, Alessandra, Hwang, Jessica P.
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2018
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6247917/
https://ncbi.nlm.nih.gov/pubmed/30290904
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/S2352-3026(18)30152-2
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi